Please assess the completion status of the following clinical trial:

Trial Title: Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria (abbreviated):~* Moderate to severe lower eyelid steatoblepharon (LESS score of 2-4 bilaterally)~* Men and women 40-70 years old~* Healthy facial skin~* Must understand and provide informed consent~Exclusion Criteria (abbreviated):~* Best corrected visual acuity worse than 20/40 in either eye~* Regular use of ophthalmic medication in either eye~* Planned use of contact lenses during the study~* Any history of lower eyelid surgery

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- XOPH5 Ointment (Type: EXPERIMENTAL): XOPH5 Ointment is the investigational drug to be studied.
- Placebo Ointment (Type: PLACEBO_COMPARATOR): Placebo is an ointment that matches XOPH5 Ointment but lacks the active ingredient.

Based on this trial design, predict the completion outcome and termination type (if applicable).